• Deutsch
  • Home
  • Isotopes
  • Application
  • References
  • History
  • News
  • Career
  • Contact
  • Service
  • Cern

    Industrial Hot Cell Solution

  • Workbench

    Safety Work Bench SWB15, for handling of Tc-99m and Ga-68

  • Manipulator

    Facility for Material Testing

  • ITD2 Reactor

    Boxes für α/β emitters

  • KIPT

    Integrated testing devices, e.g. tensile testing

  • SDS

    Facility for the production of Tc-99m generators

  • ZRT

    Hot cell for the research on PET-radiopharmaceuticals

Isotope / Isotopes

Carbon 11

Fluor 18

Phosphor 32

Cobalt 60

Gallium 68

Yttrium 90

Technetium 99m

Molybdenum 99

Iodine 123

Iodine 124

Iodine 125

Iodine 131

Caesium 137

Lutetion 177

Iridium 192

Anwendungen / Applications

Hot cells and glove box systems for the safe handling of Alpha- and Beta emitters for therapy

Technology for the production of a wide range of radionuclides for medical or industrial use

Equipment for the production and aseptic dispensing of PET radiopharmaceuticals

Equipment for hot labs ensuring safe manufacturing of radiopharmaceuticals

Complex facilities for special applications of radioactive materials with high requirements regarding process technology and safety

Isotope Technologies Dresden GmbH will be a leading global supplier and integrator of safe, reliable and economical systems to produce radiopharmaceuticals and to handle other radioactive materials.

Based on decades of experience and latest technologies, we contribute to saving lives with our solutions by protecting people, product and the environment.

We provide value to our customers with excellent consultancy service, high quality and life-long technical service.

Press Release Eckert & Ziegler 19.06.2018

Eckert & Ziegler is Manufacturing Partner for Bayer’s Innovative Targeted Thorium Conjugates in Europe

Berlin, 19 June 2018. Eckert & Ziegler AG, a specialist for scientific, medical, and industrial applications of radioisotopes, has been selected as manufacturing partner for clinical supply of Bayer's innovative Targeted Thorium Conjugates (TTCs) in Europe. TTCs are a versatile, next-generation targeted alpha therapy (TAT). The approach uses tumor targeting molecules such as antibodies that carry alpha-particle emitting Thorium-227 to the tumor. TTCs have the potential to be used in a broad range of tumors, and also for patients who are refractory to chemotherapy or conventional targeted oncologics. Bayer has established scalable Good Manufacturing Practices (GMP) processes for the alpha-emitter Thorium-227. Eckert & Ziegler will provide the infrastructure for handling, manufacture and distribution of the TTCs for the purpose of clinical trial testing in Europe.

‎”We are delighted to have been selected as a partner for this interesting and important product platform,” says Dr. André Heß, Member of the Executive Board of Eckert & Ziegler and Head of the Radiopharma Segment. “The decision demonstrates how well our Radiopharma Segment can support the requirements of innovative partners by the provision of exceptional radiopharmaceutical expertise, all of which is backed-up by a world-wide logistics infrastructure. We are excited about the potential of this innovative platform technology as Thorium-227 can be coupled with various biomolecules addressing different tumor types.”

About Eckert & Ziegler

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of isotope technology for radiation therapy and nuclear medicine and has around 800 employees worldwide. It globally provides nuclear medicine institutions with synthesis technology, quality control instruments, and pharmaceutical grade radioisotopes, among them Yttriga®, a precursor for Yttrium based oncology products, and GalliaPharm®; a Gallium-68 radionuclide generator for diagnostic applications.

Contributing to saving lives.

 

Contact:
Eckert & Ziegler AG
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, This email address is being protected from spambots. You need JavaScript enabled to view it., www.ezag.com

Sitz Berlin, Amtsgericht Charlottenburg Reg.-Nr. HRB 64997 B

Vorstand: Dr. Andreas Eckert (Vorsitzender), Dr. Harald Hasselmann, Dr. André Heß

Aufsichtsrat: Prof. Dr. Wolfgang Maennig (Vorsitzender)

  1. Double Launch!

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Referenzen / References

vtt  AS 2674799500042281440783597438 l  HZDR GESAMTLOGO S RGB  

polatom  MURRmatters green  LabelSupplier

Geschichte / History

History of the Isotope Technologies Dresden Gmbh

1964

The Origins

of the company dates back to a technical department in the isotope production of the Nuclear Research Center Rossendorf
1960s

Development of a process

for the production of Mo-99 (fission) and I-131 from irradiated tellurium dioxide
1991

Spin-off

of the Nuclear Research Center Rossendorf as Wälischmiller Dresden
2005

Project Milestone

: POLATOM: Complete hot cell complex for I-131
2008

Formation

of Isotope Technologies Dresden and entry to the radiopharmaceutical area by providing radiation protection & isotope production equipment to globally active producers
2010

Project Milestone

King Faisal Specialist Hospital & Research Centre (Saudi-Arabia) – Facility for the production of Tc-99m generators by aseptic loading
2010

Project Milestone

BRIT (India) - facility for the production of Tc-99m generators by loading and autoclaving of the generator columns
2011

Project Milestone

Dimitrovgrad (Russia) - production of Mo-99 (fission)
2014

Project Milestone

MURR (USA) - first installation in the USA – radiochemical processing, dispensing, and waste handling hot cells
2016

Project Milestone

HZDR (Germany) - PET hot cell lines for synthesis, target handling and distribution and dispensing of PET radiopharmaceuticals among GMP conditions
2017

Acquisition & Rebranding

by Eckert & Ziegler Strahlen- und Medizintechnik AG
2017

Project Milestone

VTT (Finland) – Fully customized Facility, that was developed in a close cooperation with VTT. The purpose of the facility is the examination and testing of materials from nuclear power plants.
2017

Launch

of a shielded safety work bench, that was developed for the handling of Tc-99m and Ga-68. During the design process ergonomical aspects were considered just like an industry designer was also involved.

ezag2

Isotope Technologies Dresden GmbH

Rossendorfer Ring 42
01328 Dresden

tel.: +49 351 266 34 0
fax: +49 351 266 34 10

email: itd-info@ezag.com

 

 

 

 

 

 

 

 

 

Isotope Technologies Dresden GmbH
Rossendorfer Ring 42
01328 Dresden

+49 (351) 266 34-0

 

 

 

 

 

 

 

 

 

 

 

Videos

SGS ISO 9001 TCL

Imprint
Privacy Policy
Standard Terms and Conditions
Terms of Conditions and Payments (TCP)

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok Decline